Evidence map›Paper›PMID 26979502›Full record

ArticleNature reviews. Molecular cell biology2016

Metabolomics: beyond biomarkers and towards mechanisms.

Caroline H Johnson, Julijana Ivanisevic, Gary Siuzdak

Registry-linked trialAbstract read
In one paragraph

Article in Nature reviews. Molecular cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07151183 (A Prospective Research on Diagnosis, Prognosis, and Mechanisms of Panvascular Disease), which is not on this map. Cited by 1,419 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,419citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07151183 recruitingnot on this mapstarted 2024, after this paper: background citation

A Prospective Research on Diagnosis, Prognosis, and Mechanisms of Panvascular Disease

Typeobservational_patient_registrySponsorJinwei TianRan2024 to 2030Enrolled1,000ConditionsPanvascular Diseases, Cardiovascular DiseasesArmsNo intervention
3 · Its place in the literature

Who cites it

1,419 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

1,359 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Caroline H JohnsonDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, 60 College Street, New Haven, Connecticut 06520, USA.
Julijana IvanisevicMetabolomics Research Platform, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 19, 1005 Lausanne, Switzerland.
Gary SiuzdakScripps Center for Metabolomics and Mass Spectrometry, Departments of Chemistry, Molecular and Computational Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Funding

Pharmacokinetics and Drug-Drug InteractionsP01DA028555 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ALNOUTI, YAZEN · 2010 to 2019
$16.8M
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS SynergyP01DA026146 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2008 to 2010
$2.9M
XCMS Metabolomic Data TechnologyR01GM114368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SIUZDAK, GARY E · 2015 to 2018
$1.5M
NIDA NIH HHS P01 DA026146NIDA NIH HHS P01 DA028555NIGMS NIH HHS R01 GM114368
6 · The paper itself

Abstract

Metabolomics, which is the profiling of metabolites in biofluids, cells and tissues, is routinely applied as a tool for biomarker discovery. Owing to innovative developments in informatics and analytical technologies, and the integration of orthogonal biological approaches, it is now possible to expand metabolomic analyses to understand the systems-level effects of metabolites. Moreover, because of the inherent sensitivity of metabolomics, subtle alterations in biological pathways can be detected to provide insight into the mechanisms that underlie various physiological conditions and aberrant processes, including diseases.

Indexed as

MetabolomicsAnimalsBiomarkersHumansMetabolic Networks and PathwaysMetabolomeSystems BiologyBiomarkers

Identifiers

PMID26979502
PMCPMC5729912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.